The impact and cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine

Abstract

Objectives: To estimate the cost-effectiveness of a harm reduction intervention amongst injecting drug users (IDUs) in Odessa, Ukraine. To explore how the cost-effectiveness changes if the intervention were scaled-up to 60%, as recommended by WHO/UNAIDS .
Study Design: Economic provider's costs were estimated. A dynamic mathematical model, fitted to epidemiological data, projected the intervention's impact. The cost per HIV-infection averted for different intervention coverages was estimated.
Results: From September 1999-August 2000, at the current coverage of between 20-38% and an IDU HIV-prevalence of 54%, projections suggest 792 HIV-infections averted, a 22% decrease in IDU HIV-incidence, but a 1% increase in IDU HIV-prevalence. Cost per HIV-infection averted was $97. Scaling up the intervention to reach 60% of IDUs remains cost-effective, and reduces HIV-prevalence by 4% over 5-years.
Conclusion: At the current coverage, the harm reduction intervention in Odessa is cost-effective, but is unlikely to reduce IDU HIV-prevalence in the short-term. To reduce HIV-prevalence more resources are needed to increase coverage.

Citation

Sexually Transmitted Diseases (2006) 33 (10 Suppl.) S89-S102 [doi: 10.1097/01.olq.0000221335.80508.fa]

The impact and cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.